[Antibacterial agent Oftaquix efficacy in cataract phacoemulsification].

Clinical study is performed to estimate the efficacy of Oftaquix in cataract phacoemulsification with intraocular lens (IOL) implantation. Obtained results show that Oftaquix prescription two days before surgery allows to eliminate bacterial agents from conjunctival cavity on the day of surgery. Significant and stable antibacterial effect is demonstrated. Bacteriological study on the 19-21 day after surgery revealed bacterial growth in 6.7% of patients in experimental group and in 30% of patients in control group.